Not yet taking people in Franciaország1. fázis
A phase 1, open-label, dose-escalation and dose-expansion study evaluating the safety, feasability and efficacy of ODI-2001 vaccine, a personalized immunotherapy, in patients with metastatic or locally advanced colon cancer of pancreatic cancer
Key facts
- Where
- Besançon és Dijon, FranciaországSee the 2 sites
- Phase
- 1. fázis
Where in Franciaország
- CHRU Jean MinjozBesançon, FranciaországToborzás még nem indult
- Centr Georges Francois LeclercDijon, FranciaországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centr Georges Francois Leclerc
- Trial code
- EU 2025-523172-23-00
- Record updated
- 2026. február 10.